Episalvan

RSS

birch bark extract

Withdrawn
This medicine is now withdrawn from use in the European Union.

Overview

The marketing authorisation for Episalvan has been withdrawn at the request of the marketing-authorisation holder.

This EPAR was last updated on 15/07/2022

Authorisation details

Product details
Name
Episalvan
Agency product number
EMEA/H/C/003938
Active substance
Betulae cortex
International non-proprietary name (INN) or common name
birch bark extract
Therapeutic area (MeSH)
  • Wounds and Injuries
  • Wound Healing
Anatomical therapeutic chemical (ATC) code
D03AX13
Publication details
Marketing-authorisation holder
Amryt AG
Revision
7
Date of issue of marketing authorisation valid throughout the European Union
14/01/2016
Contact address
Streiflingsweg 11
75223 Niefern-Oschelbronn
Germany

Product information

07/06/2022 Episalvan - EMEA/H/C/003938 -

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Preparations for treatment of wounds and ulcers

Therapeutic indication

Treatment of partial thickness wounds in adults. See sections 4.4 and 5.1 in Product Information with respect to type of wounds studied.

Assessment history

How useful was this page?

Add your rating